SCHEMBL7942491

SCHEMBL7942491

CC(=O)N(C)CCN(C)C(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.48
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
CHRM2 P08172 3/20 0.36
CHRM4 P08173 3/20 0.36
CHRM5 P08912 3/20 0.36
CHRM3 P20309 3/20 0.36
ALDH1A1 P00352 4/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
ACHE P22303 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 2/20 0.32
TRPA1 O75762 1/20 0.32
THPO P40225 1/20 0.31
FFAR3 O14843 1/20 0.31
LCK P06239 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179676 0.91 CHRM1 (0.48) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL20756157 0.88 CHRM1 (0.41) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL8854824 0.87 CHRM1 (0.44) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL24660237 0.86 CHRM1 (0.39) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL22623936 0.86 CHRM1 (0.39) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL19945231 0.86 ALDH1A1 (0.43) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL24313164 0.86 CHRM1 (0.39) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL24773596 0.86 CHRM1 (0.39) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL15223875 0.86 CHRM1 (0.39) CHRM1MTNR1AMTNR1BCHRM2CHRM4
SCHEMBL50119 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116376532-A Carbon dioxide foam flooding channeling-preventing agent suitable for fractured ultralow permeability reservoir and application thereof 西南石油大学 2023-07-04 CN disclosed
CN-116285934-A Gel channeling inhibitor suitable for expanding sweep volume of carbon dioxide flooding of ultralow permeability reservoir and application thereof 西南石油大学 2023-06-23 CN disclosed
WO-2022253033-A1 CHEMICAL COUPLING LINKER AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-12-08 WO disclosed
WO-2022052823-A1 SMALL-MOLECULE CONJUGATE AND USE THEREOF 上海邈基生物科技有限公司 2022-03-17 WO disclosed
EP-3149212-B1 ELECTROCHEMICAL METHODS AND COMPOUNDS FOR THE DETECTION OF ENZYMES UNIV GEORGIA STATE RES FOUND (US) 2020-08-26 EP disclosed
WO-2019217591-A1 ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-11-14 WO disclosed
WO-2019136487-A2 STEROIDS AND ANTIBODY-CONJUGATES THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2019-07-11 WO disclosed
EP-2975620-B1 ALUMINUM ELECTROLYTIC CAPACITOR-USE ELECTROLYTIC SOLUTION AND ALUMINUM ELECTROLYTIC CAPACITOR USING SAME SANYO CHEMICAL IND LTD (JP) 2019-05-22 EP disclosed
WO-2019034692-A1 SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS INFLAZOME LIMITED (IE) 2019-02-21 WO disclosed
WO-2019034688-A1 NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS INFLAZOME LIMITED (IE) 2019-02-21 WO disclosed
US-9793059-B2 Electrolytic solution for aluminum electrolytic capacitor and aluminum electrolytic capacitor using the same SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2017-10-17 US disclosed
US-20170102349-A1 ELECTROCHEMICAL METHODS AND COMPOUNDS FOR THE DETECTION OF ENZYMES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-04-13 US disclosed
US-20160020036-A1 ELECTROLYTIC SOLUTION FOR ALUMINUM ELECTROLYTIC CAPACITOR AND ALUMINUM ELECTROLYTIC CAPACITOR USING THE SAME SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2016-01-21 US disclosed
EP-2975620-A1 ALUMINUM ELECTROLYTIC CAPACITOR-USE ELECTROLYTIC SOLUTION AND ALUMINUM ELECTROLYTIC CAPACITOR USING SAME Sanyo Chemical Industries, Ltd. (JP) 2016-01-20 EP disclosed
US-9234171-B2 Stem cell differentiation using novel light-responsive hydrogels RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-01-12 US disclosed
EP-0693466-B1 Process for the preparation of aromatic fluorinated compounds and diamides BAYER AG (DE) 2001-10-17 EP disclosed
US-5672765-A Process for the preparation of aromatic fluorinated compounds and novel diamides BAYER AKTIENGESELLSCHAFT (DE) 1997-09-30 US disclosed
EP-0693466-A1 Process for the preparation of aromatic fluorinated compounds and diamides BAYER AG (DE) 1996-01-24 EP disclosed
US-3954607-A Permselective membranes of diacyl hydrazide-containing aromatic polymers having selected metals complexed therewith E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170102349-A1 ELECTROCHEMICAL METHODS AND COMPOUNDS FOR THE DETECTION OF ENZYMES EPX, DNASE1, DERA CHRM1 2694/4885MTNR1A 3954/4885MTNR1B 4233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.